当前位置:首页 - 行情中心 - 康美药业(600518) - 财务分析 - 现金流量表

康美药业

(600518)

  

流通市值:283.36亿  总市值:283.49亿
流通股本:138.22亿   总股本:138.29亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,001,236,403.642,421,203,920.091,170,064,216.034,987,299,665.52
  收到其他与经营活动有关的现金78,876,328.1267,021,985.4245,284,716.0784,174,021.01
  经营活动现金流入小计4,080,112,731.762,488,225,905.511,215,348,932.15,071,473,686.53
  购买商品、接受劳务支付的现金3,016,632,529.21,947,835,816.381,008,105,159.484,150,416,180.6
  支付给职工以及为职工支付的现金557,655,764.08372,580,697.57191,327,657.34728,977,488.19
  支付的各项税费103,929,261.4371,964,361.8633,791,190.43295,280,233.59
  支付其他与经营活动有关的现金264,052,677.25177,961,877.3883,510,034.87324,432,541.45
  经营活动现金流出小计3,942,270,231.962,570,342,753.191,316,734,042.125,499,106,443.83
  经营活动产生的现金流量净额137,842,499.8-82,116,847.68-101,385,110.02-427,632,757.3
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额20,080,726.328,258,543.38502,211.38164,327,079.18
  处置子公司及其他营业单位收到的现金净额---27,300,000
  收到的其他与投资活动有关的现金---10,000,000
  投资活动现金流入小计20,080,726.328,258,543.38502,211.38201,627,079.18
  购建固定资产、无形资产和其他长期资产支付的现金74,116,991.925,543,694.547,285,235.2561,712,075.96
  投资活动现金流出小计74,116,991.925,543,694.547,285,235.2561,712,075.96
  投资活动产生的现金流量净额-54,036,265.58-17,285,151.16-6,783,023.87139,915,003.22
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,400,000500,000-1,145,000
  其中:子公司吸收少数股东投资收到的现金1,400,000500,000-1,145,000
  取得借款收到的现金---100,000
  收到其他与筹资活动有关的现金187,093,185.9972,933,804.2148,056,627.59230,841,036.22
  筹资活动现金流入小计188,493,185.9973,433,804.2148,056,627.59232,086,036.22
  偿还债务支付的现金43,500,000--100,273.89
  分配股利、利润或偿付利息支付的现金45,878.445,878.4-750,000
  其中:子公司支付给少数股东的股利、利润45,878.445,878.4-750,000
  支付其他与筹资活动有关的现金27,282,963.2418,855,107.8710,229,991.9356,421,148.85
  筹资活动现金流出小计70,828,841.6418,900,986.2710,229,991.9357,271,422.74
  筹资活动产生的现金流量净额117,664,344.3554,532,817.9437,826,635.66174,814,613.48
四、汇率变动对现金及现金等价物的影响-6,353.221,732.58--3,347.27
五、现金及现金等价物净增加额201,464,225.35-44,867,448.32-70,341,498.23-112,906,487.87
  加:期初现金及现金等价物余额842,979,871.77842,979,871.77842,979,871.77955,886,359.64
  期末现金及现金等价物余额1,044,444,097.12798,112,423.45772,638,373.54842,979,871.77
补充资料:
  净利润-18,315,653.88-12,082,198.72
  资产减值准备-798,690.5-142,740,044.03
  固定资产和投资性房地产折旧-130,325,915.11-267,204,448.74
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-130,325,915.11-267,204,448.74
  无形资产摊销-8,930,044.4-19,938,732.53
  长期待摊费用摊销-10,241,512.7-33,415,443.06
  处置固定资产、无形资产和其他长期资产的损失--286,015.92--39,470,945.23
  固定资产报废损失-686,507.3-2,351,843.43
  公允价值变动损失-919.26-1,838.54
  财务费用-3,762,182.6-21,387,136.02
  投资损失--231,879.41--59,181,059.28
  递延所得税-1,250,650.31-2,289,138.24
  其中:递延所得税资产减少-4,127,412.28-27,122,702.91
    递延所得税负债增加--2,876,761.97--24,833,564.67
  存货的减少-69,178,861.68--34,319,833.1
  经营性应收项目的减少--153,489,458.71--502,639,019.38
  经营性应付项目的增加--146,396,862.81--347,406,003.41
  现金的期末余额-798,112,423.45-842,979,871.77
  减:现金的期初余额-842,979,871.77-955,886,359.64
  现金及现金等价物的净增加额--44,867,448.32--112,906,487.87
公告日期2025-10-312025-08-302025-04-302025-04-19
审计意见(境内)标准无保留意见
TOP↑